Schedule 13G ownership disclosure
NORTRAN PHARMACEUTICALS INC
Security class unavailable
Event date: 2020-05-26
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 12.0700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001214659-20-005020
- Form type
- SC 13G
- Filer
- Correvio Pharma Corp.
- CIK
- CIK 1036141
- Filed
- May 26, 2020
- Reporting period
- May 26, 2020
- Description
- Schedule 13G beneficial ownership